Results 61 to 70 of about 302,501 (282)

Opioid Dosage Levels, Concurrent Risk Factors and Self-Perceptions among Chronic Pain, Opioid-Managed Individuals at Elevated Risk for Opioid Overdose

Pharmaceuticals, 2021
While current opioid prescribing guidelines highlight a dose-response relationship between therapeutic management and overdose risk, other concurrent risk factors have also been identified.
Matthew S. Ellis, Zachary A. Kasper, Mark Gold, Theodore J. Cicero   +3 more
doaj   +1 more source

Semaglutide and Opioid Overdose Risk in Patients With Type 2 Diabetes and Opioid Use Disorder

JAMA Network Open
This cohort study uses emulation target trial methods to evaluate whether semaglutide is associated with lower rates of opioid overdose among patients with type 2 diabetes (T2D) and opioid use disorder (OUD).
William Wang, Nora D. Volkow, Q. Wang, Nathan A. Berger, P. Davis, D. Kaelber, Rong Xu   +6 more
semanticscholar   +1 more source

No obvious effect on mortality from a patient choice reform expanding access to opioid disorder treatment – results from a natural experiment of policy change in Sweden

Substance Abuse Treatment, Prevention, and Policy, 2023
Background Opioid-related overdose deaths remain a common cause of death in many settings, and opioid maintenance treatment is evidence-based for the treatment of opioid use disorders.
Anders Håkansson, Sahar Janfada-Baloo, Jonas Berge   +2 more
doaj   +1 more source

Association of Household Opioid Availability With Opioid Overdose

JAMA Network Open, 2023
ImportancePrevious studies that examined the role of household opioid prescriptions in opioid overdose risk were limited to commercial claims, did not include fatal overdoses, and had limited inclusion of household prescription characteristics. Broader research is needed to expand understanding of the risk of overdose.ObjectiveTo assess the role of ...
Hendricks, Michelle A., El Ibrahimi, Sanae, Ritter, Grant A., Flores, Diana, Fischer, Michael A., Weiss, Roger D., Wright, Dagan A., Weiner, Scott G.   +7 more
openaire   +2 more sources

Community-Based Cluster-Randomized Trial to Reduce Opioid Overdose Deaths

New England Journal of Medicine
BACKGROUND Evidence-based practices for reducing opioid-related overdose deaths include overdose education and naloxone distribution, the use of medications for the treatment of opioid use disorder, and prescription opioid safety.
Jeffrey H. Samet, N. El-Bassel, T. Winhusen, Rebecca D Jackson, E. Oga, Redonna K. Chandler, Jennifer Villani, Bridget Freisthler, Joella W Adams, Arnie Aldridge, Angelo Angerame, Denise C. Babineau, Sarah M. Bagley, Trevor Baker, P. Balvanz, Carolina Barbosa, J. Barocas, Tracy A. Battaglia, Dacia D Beard, Donna Beers, Derek Blevins, Nicholas Bove, C. Bridden, Jennifer L. Brown, Heather Bush, Joshua L. Bush, R. Caldwell, Katherine Calver, Deirdre Calvert, Aimee N. C. Campbell, J. Carpenter, R. Caspar, D. Chassler, Joan Chaya, Debbie M. Cheng, C. Cunningham, Anindita Dasgupta, James L. David, Alissa Davis, T. Dean, M. Drainoni, Barry Eggleston, Laura C. Fanucchi, Daniel J. Feaster, S. Fernandez, Wilson Figueroa, Darcy A. Freedman, Patricia R. Freeman, C. Freiermuth, Eric Friedlander, K. Gelberg, Erin B. Gibson, L. Gilbert, LaShawn M. Glasgow, D. Goddard-Eckrich, Steve Gomori, Dawn E. Gruss, Jennifer Gulley, Damara N. Gutnick, Megan E. Hall, Nicole Harger Dykes, Sarah L. Hargrove, Kristin Harlow, Aumani Harris, Daniel R. Harris, Donald Helme, JaNae Holloway, Juanita Hotchkiss, Terry Huang, Timothy R. Huerta, Timothy Hunt, A. Hyder, Van Ingram, Tim Ingram, Emily Kauffman, Jennifer Kimball, Elizabeth N. Kinnard, Charles E. Knott, Hannah K. Knudsen, M. Konstan, Sarah Kosakowski, Marc LaRochelle, Hannah Leaver, Patricia LeBaron, R. C. Lefebvre, Frances R. Levin, Nikki Lewis, Nikki Lewis, Michelle R. Lofwall, David W. Lounsbury, Jamie Luster, Michael S Lyons, Aimee Mack, Katherine R. Marks, Stephanie Marquesano, Rachel Mauk, A. McAlearney, K. McConnell, M. McGladrey, Jason T McMullan, Jennifer Miles, Rosie Munoz Lopez, A. Nelson, Jessica Neufeld, Lisa Newman, Trang Q Nguyen, Edward V. Nunes, Devin A. Oller, Carrie B. Oser, D. Oyler, Sharon Pagnano, Theodore V. Parran, J. Powell, K. Powers, William Ralston, Kelly S. Ramsey, Bruce D. Rapkin, Jennifer Reynolds, Monica F. Roberts, W. Robertson, Peter Rock, Emma Rodgers, Sandra Rodriguez, Maria Rudorf, Shawn Ryan, Pamela Salsberry, Monika Salvage, Nasim S. Sabounchi, Merielle Saucier, Caroline Savitzky, Bruce R. Schackman, Elizabeth Schady, Eric E. Seiber, Aimee Shadwick, Abigail B Shoben, Michael D Slater, Svetla Slavova, Drew Speer, Joel Sprunger, Laura E. Starbird, Michele Staton, Michael D Stein, D. Stevens-Watkins, T. Stopka, A. Sullivan, H. Surratt, Rachel Sword Cruz, Jeffery C. Talbert, Jessica L. Taylor, Katherine Thompson, Nathan Vandergrift, R. Vickers-Smith, Deanna J Vietze, Daniel M. Walker, Alexander Y. Walley, Scott T. Walters, Roger D. Weiss, P. Westgate, E. Wu, April M. Young, G. Zarkin, Sharon L. Walsh   +161 more
semanticscholar   +1 more source

Take-home naloxone programs for suspected opioid overdose in community settings: a scoping umbrella review

BMC Public Health, 2021
Background Opioid related overdoses and overdose deaths continue to constitute an urgent public health crisis. The implementation of naloxone programs, such as ‘take-home naloxone’ (THN), has emerged as a key intervention in reducing opioid overdose ...
A. Moustaqim-Barrette, Damon Dhillon, J. Ng, K. Sundvick, Farihah Ali, T. Elton-Marshall, P. Leece, K. Rittenbach, Max Ferguson, J. Buxton   +9 more
semanticscholar   +1 more source

Factors associated with opioid overdose during medication-assisted treatment: How can we identify individuals at risk?

Harm Reduction Journal, 2021
Background Due to the loss of tolerance to opioids during medication-assisted treatment (MAT), this period may represent a time of heightened risk for overdose.
Vivian Y. O. Au, Tea Rosic, Nitika Sanger, Alannah Hillmer, Caroul Chawar, Andrew Worster, David C. Marsh, Lehana Thabane, Zainab Samaan   +8 more
doaj   +1 more source

Opioid Overdose After Medication for Opioid Use Disorder Initiation Following Hospitalization or ED Visit

JAMA Network Open
This cohort study assesses the association of medication for opioid use disorder (MOUD) initiation after hospitalization or an emergency department (ED) visit with subsequent fatal or nonfatal opioid overdose at 6 and 12 months.
Scott G. Weiner, Kacey Little, Jiah Yoo, D. Flores, C. Hildebran, Dagan Wright, Grant A. Ritter, Sanae El Ibrahimi   +7 more
semanticscholar   +1 more source

“They think you’re trying to get the drug”: Qualitative investigation of chronic pain patients’ health care experiences during the opioid overdose epidemic in Canada

Canadian journal of pain = Revue canadienne de la douleur, 2021
Background: The opioid overdose epidemic has led health care providers to increased vigilance for opioid-related risks in the treatment of chronic non-cancer pain (CNCP). Media have conveyed stigmatizing representations of opioid analgesics.
Lise Dassieu, Angela Heino, Élise Develay, Jean-Luc Kaboré, M. G. Pagé, Gregg Moor, Maria Hudspith, M. Choinière   +7 more
semanticscholar   +1 more source

Opioid-related overdose and chronic use following an initial prescription of hydrocodone versus oxycodone.

PLoS ONE, 2022
BackgroundHydrocodone and oxycodone are prescribed commonly to treat pain. However, differences in risk of opioid-related adverse outcomes after an initial prescription are unknown.
Scott G Weiner, Michelle A Hendricks, Sanae El Ibrahimi, Grant A Ritter, Sara E Hallvik, Christi Hildebran, Roger D Weiss, Edward W Boyer, Diana P Flores, Lewis S Nelson, Peter W Kreiner, Michael A Fischer   +11 more
doaj   +1 more source